ThromboGenics completes warrant exercise

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Date completed: 10/27/10 Type: Warrant exercise Raised: €2.8 million ($3.9 million) Shares: 289,000 Shares after...